Marcella Marconi

882 total citations
15 papers, 526 citations indexed

About

Marcella Marconi is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marcella Marconi has authored 15 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marcella Marconi's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Marcella Marconi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Marcella Marconi collaborates with scholars based in Italy, United States and Netherlands. Marcella Marconi's co-authors include Giuseppe Zamboni, Giuseppe Bogina, Gianluigi Lunardi, Enrico Munari, Matteo Brunelli, Lorenzo Moretta, George J. Netto, Guido Martignoni, Marco Sommaggio and Paola Vacca and has published in prestigious journals such as Cancer Research, Annals of Oncology and Frontiers in Immunology.

In The Last Decade

Marcella Marconi

15 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcella Marconi Italy 13 401 185 152 139 76 15 526
Maximilian Aigner Germany 7 458 1.1× 115 0.6× 182 1.2× 194 1.4× 143 1.9× 7 668
Valerie Jakrot Australia 7 477 1.2× 107 0.6× 168 1.1× 193 1.4× 128 1.7× 8 558
Alessandra Anna Prete Italy 9 388 1.0× 158 0.9× 144 0.9× 95 0.7× 66 0.9× 27 497
Andy Karabajakian France 9 537 1.3× 246 1.3× 84 0.6× 138 1.0× 103 1.4× 19 684
Eriko Aimono Japan 12 192 0.5× 128 0.7× 118 0.8× 54 0.4× 84 1.1× 40 374
Sai‐Yin Cheung Hong Kong 13 234 0.6× 122 0.7× 92 0.6× 63 0.5× 72 0.9× 16 380
Jacob Elebro Sweden 14 345 0.9× 80 0.4× 101 0.7× 108 0.8× 155 2.0× 28 492
Zuzana Kos Canada 11 317 0.8× 56 0.3× 129 0.8× 154 1.1× 121 1.6× 32 512
Mariacarla Andreozzi Italy 10 607 1.5× 407 2.2× 150 1.0× 176 1.3× 177 2.3× 19 804
Amy Meister United States 7 551 1.4× 240 1.3× 62 0.4× 136 1.0× 125 1.6× 9 674

Countries citing papers authored by Marcella Marconi

Since Specialization
Citations

This map shows the geographic impact of Marcella Marconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcella Marconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcella Marconi more than expected).

Fields of papers citing papers by Marcella Marconi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcella Marconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcella Marconi. The network helps show where Marcella Marconi may publish in the future.

Co-authorship network of co-authors of Marcella Marconi

This figure shows the co-authorship network connecting the top 25 collaborators of Marcella Marconi. A scholar is included among the top collaborators of Marcella Marconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcella Marconi. Marcella Marconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Munari, Enrico, Giulia Querzoli, Matteo Brunelli, et al.. (2022). Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection. Frontiers in Immunology. 13. 954910–954910. 5 indexed citations
2.
Munari, Enrico, Marcella Marconi, Giulia Querzoli, et al.. (2021). Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer. Frontiers in Immunology. 12. 680973–680973. 24 indexed citations
3.
Munari, Enrico, Anna Caliò, Diego Segala, et al.. (2021). TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study. Modern Pathology. 35(3). 376–385. 28 indexed citations
4.
Fiore, Piera Filomena, Paola Vacca, Nicola Tumino, et al.. (2021). Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages. Cancers. 13(2). 224–224. 13 indexed citations
5.
Munari, Enrico, Giuseppe Zamboni, Gianluigi Lunardi, et al.. (2019). PD-L1 expression in non–small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory-developed test using clone E1L3N in comparison with 22C3 and SP263 assays. Human Pathology. 90. 54–59. 24 indexed citations
6.
Huergo-Zapico, Leticía, Monica Parodi, Claudia Cantoni, et al.. (2018). NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines. Cancer Research. 78(14). 3913–3925. 59 indexed citations
7.
Munari, Enrico, Giuseppe Zamboni, Gianluigi Lunardi, et al.. (2018). PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263. Oncotarget. 9(54). 30465–30471. 28 indexed citations
8.
Munari, Enrico, Giulio Rossi, Giuseppe Zamboni, et al.. (2018). PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non–Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs. The American Journal of Surgical Pathology. 42(10). 1384–1389. 73 indexed citations
9.
Munari, Enrico, Giuseppe Zamboni, Marcella Marconi, et al.. (2018). Expression of programmed cell death ligand 1 in non–small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 assay. Cancer Cytopathology. 127(1). 52–61. 45 indexed citations
10.
Munari, Enrico, Giuseppe Zamboni, Marcella Marconi, et al.. (2017). PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability. Oncotarget. 8(52). 90123–90131. 81 indexed citations
11.
Bogina, Giuseppe, Enrico Munari, Marcella Marconi, et al.. (2015). Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome. Annals of Oncology. 26. vi137–vi137. 3 indexed citations
12.
Bogina, Giuseppe, Enrico Munari, Matteo Brunelli, et al.. (2015). Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome. Histopathology. 68(3). 422–432. 51 indexed citations
13.
Bogina, Giuseppe, Gianluigi Lunardi, Matteo Brunelli, et al.. (2013). P16 but not retinoblastoma expression is related to clinical outcome in no-special-type triple-negative breast carcinomas. Modern Pathology. 27(2). 204–213. 13 indexed citations
14.
Bogina, Giuseppe, Giuseppe Zamboni, Anna Sapino, et al.. (2012). Comparison of Anti–Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer. American Journal of Clinical Pathology. 138(5). 697–702. 27 indexed citations
15.
Bogina, Giuseppe, Laura Bortesi, Marcella Marconi, et al.. (2011). Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 459(1). 1–10. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maximilian Aigner Breakdown of academic impact, for papers by Valerie Jakrot Breakdown of academic impact, for papers by Alessandra Anna Prete Breakdown of academic impact, for papers by Andy Karabajakian Breakdown of academic impact, for papers by Eriko Aimono Breakdown of academic impact, for papers by Sai‐Yin Cheung Breakdown of academic impact, for papers by Jacob Elebro Breakdown of academic impact, for papers by Zuzana Kos Breakdown of academic impact, for papers by Mariacarla Andreozzi Breakdown of academic impact, for papers by Amy Meister
Rankless by CCL
2026